Skip to content
Entourage
Case studyMedTech

Regulatory Strategy for 510(k) Clearance and Successful US Market Entry

An international MedTech manufacturer

An international MedTech manufacturer was preparing to enter the US market on a fixed timeline and without experience of FDA requirements. Entourage developed the regulatory strategy for the 510(k) clearance.

The challenge

The situation

A fixed timeline put the timely product launch at risk, while limited experience of FDA requirements created uncertainty. Open CE documentation added further delay, and unclear clinical evidence complicated the marketing claims.

Our approach

What we delivered

01

Classifying the product to confirm the 510(k) clearance pathway

02

Managing the integration of the EU documentation through a gap analysis

03

Coordinating with the FDA to clarify marketing claims via the Q-Sub process

04

Project management: scheduling and resource alignment for the 510(k) approach

The outcome

Results & impact

Improved schedule predictability

Planning for the clearance was made more robust and easier to forecast.

Smooth market entry

Entry into the US market proceeded without process delays.

Greater efficiency achieved

Resources and the schedule were aligned with the 510(k) approach.

In summary

The strategic market entry in the US was achieved on schedule, significantly strengthening the market position.

Regulations & standards considered

  • FDA 510(k) Premarket Notification (21 CFR Part 807)
Sources
  • https://theentourage.de/case-study/fda-510k-market-clearance/ (live case study, accessed 2026-06-14)

Your project

A comparable project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? +49 89 4161170-0
info@theentourage.de

  • Reply usually within one working day
  • 4 offices: DE · CH · IT · US
  • 100% life sciences